Next Article in Journal
CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin
Next Article in Special Issue
Genomics of Smoldering Multiple Myeloma: Time for Clinical Translation of Findings?
Previous Article in Journal
Activation of DNA Damage Tolerance Pathways May Improve Immunotherapy of Mesothelioma
Previous Article in Special Issue
The Role of lncRNAs in the Pathobiology and Clinical Behavior of Multiple Myeloma
 
 
Review

Article Versions Notes

Cancers 2021, 13(13), 3213; https://doi.org/10.3390/cancers13133213
Action Date Notes Link
article xml file uploaded 28 June 2021 07:17 CEST Original file -
article xml uploaded. 28 June 2021 07:17 CEST Update -
article pdf uploaded. 28 June 2021 07:17 CEST Version of Record -
article html file updated 28 June 2021 07:19 CEST Original file -
article xml file uploaded 28 June 2021 07:59 CEST Update -
article xml uploaded. 28 June 2021 07:59 CEST Update https://www.mdpi.com/2072-6694/13/13/3213/xml
article pdf uploaded. 28 June 2021 07:59 CEST Updated version of record https://www.mdpi.com/2072-6694/13/13/3213/pdf
article html file updated 28 June 2021 08:00 CEST Update -
article html file updated 27 July 2022 02:17 CEST Update https://www.mdpi.com/2072-6694/13/13/3213/html
Back to TopTop